6195 related articles for article (PubMed ID: 25767949)
21. Adolescent Pregnancy Guidelines.
Fleming N; O'Driscoll T; Becker G; Spitzer RF;
J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
[TBL] [Abstract][Full Text] [Related]
22. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
23. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women.
Singh S; Best C; Dunn S; Leyland N; Wolfman WL
J Obstet Gynaecol Can; 2018 May; 40(5):e391-e415. PubMed ID: 29731212
[TBL] [Abstract][Full Text] [Related]
24. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
25. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
27. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2012 May; (5):CD005073. PubMed ID: 22592701
[TBL] [Abstract][Full Text] [Related]
28. Interventions to reduce haemorrhage during myomectomy for fibroids.
Kongnyuy EJ; Wiysonge CS
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD005355. PubMed ID: 25125317
[TBL] [Abstract][Full Text] [Related]
29. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
[TBL] [Abstract][Full Text] [Related]
30. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
[TBL] [Abstract][Full Text] [Related]
31. Gynaecological and obstetric management of women with inherited bleeding disorders.
Demers C; Derzko C; David M; Douglas J;
J Obstet Gynaecol Can; 2005 Jul; 27(7):707-32. PubMed ID: 16100628
[TBL] [Abstract][Full Text] [Related]
32. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
33. Uterine fibroid management: from the present to the future.
Donnez J; Dolmans MM
Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
[TBL] [Abstract][Full Text] [Related]
34. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.
Istre O
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788
[TBL] [Abstract][Full Text] [Related]
35. Abnormal uterine bleeding in pre-menopausal women.
Singh S; Best C; Dunn S; Leyland N; Wolfman WL;
J Obstet Gynaecol Can; 2013 May; 35(5):473-475. PubMed ID: 23756279
[TBL] [Abstract][Full Text] [Related]
36. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
37. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
38. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
40. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
